Nitroglycerin provocation in normal subjects is not a useful human migraine model?

Cephalalgia

Volumn 30, Issue 8, 2010, Pages 928-932

  Tvedskov, J F ^a   Iversen, H K ^a   Olesen, J ^a   Tfelt Hansen, P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Aspirin; Glyceryl trinitrate; Human headache model; Zolmitriptan

Indexed keywords

ACETYLSALICYLIC ACID; GLYCERYL TRINITRATE; NITRIC OXIDE; PLACEBO; ZOLMITRIPTAN; ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXAZOLIDINONE DERIVATIVE; SEROTONIN AGONIST; TRYPTAMINE DERIVATIVE; VASODILATOR AGENT;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE MODEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXPERIMENTAL DESIGN; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; MIGRAINE; MIGRAINE WITHOUT AURA; NORMAL HUMAN; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER; BIOLOGICAL MODEL; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; INTRAVENOUS DRUG ADMINISTRATION;

ADULT; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIGRAINE DISORDERS; MODELS, BIOLOGICAL; NITROGLYCERIN; OXAZOLIDINONES; SEROTONIN AGONISTS; TRYPTAMINES; VASODILATOR AGENTS; YOUNG ADULT;

EID: 78349274558     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.02014.x     Document Type: Article

References (18)

1. Olesen J, Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. TIPS 1994; 15: 149-153. (Pubitemid 24156497)
2. Iversen HK, Olesen J, Tfelt-Hansen P. Intravenous nitro-glycerin as an experimental model of vascular headache. Basic characteristics. Pain 1989; 38: 17-24. (Pubitemid 19184833)
3. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8: 1-96.
4. Tfelt-Hansen P, Steiner TJ. Over-the-counter triptans for migraine: what are the implications? CNS Drugs 2007; 21: 877-83. (Pubitemid 47557103)
5. von Graffenried B, Hill RC. Headache as a model for testing mild analgesics. Res Clin Stud Headache 1978; 6: 103-109.
6. von Grafferied B, Hill RC, Nuesch E. Headache as a model for assessing mild analgesic drugs. J Clin Pharmacol 1980; 20: 131-144. (Pubitemid 10067089)
7. Barden J, Edwards JE, McQuay HJ, Moore AR. Pain and analgesic response after third molar extraction and other postsurgical pain. Pain 2004; 107: 86-90. (Pubitemid 38058702)
8. Lampl C, Voelker M, Diener HC. Efficacy and safety of 1,000mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. J Neurol 2007; 254: 705-712. (Pubitemid 47012463)
9. Kaube H, Hoskin KL, Goadsby PJ. Intravenous acetyl-salicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat. Headache 1993; 33: 541-544. (Pubitemid 23346602)
10. Jakubowski M, Levy D, Kainz V, Zhang XC, Kosaras B, Burstein R. Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion. Neuroscience 2007; 148: 573-583. (Pubitemid 47362497)
11. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine. A comparative review of pharmacology, phar-macokinetics and efficacy. Drugs 2000; 60: 1259-1287. (Pubitemid 32039386)
12. Iversen HK, Olesen J. Headache induced by nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia 1996; 16: 412-418. (Pubitemid 26338471)
13. Saxena PR, Tfelt-Hansen P. Triptans, 5HT1B/1D ago-nists in the acute treatment of migraine. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches, 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2006, p.469-503.
14. de Hoon JN, Willigers JM, Troost J, Struijker-Boudier HA, Van Bortel LM. Vascular effects of 5-HT1B/1D-receptor agonist in patients with migraine headaches. Clin Pharmacol Ther 2000; 68: 418-426.
15. Sakai M, Minami T, Hara I, Kitade H, Kamiyama Y, Okuda K, et al. Stimulation of nitric oxide release from rat spinal cord by prostaglandin E-2. Br J Pharmacol 1998; 123: 890-894. (Pubitemid 28085389)
16. Fullerton T, Komorowski-Swiatek D, Forrest A, Gengo FM. The pharmacodynamics of sumatriptan in nitroglycerin-induced headache. J Clin Pharmacol 1999; 39: 17-29. (Pubitemid 29053149)
17. Durham PL, Russo AF. New insight into molecular action of serotonergic antimigraine drugs. Pharmacol Ther 2002; 94: 77-92. (Pubitemid 34615959)
18. 1B/1D receptor agonist: implications for migraine therapy with triptans. Proc Natl Acad Sci USA 2004; 101: 4274-4279.